BPG is committed to discovery and dissemination of knowledge
Featured Articles
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
Browse: 190   Download: 573   Issue Date: 2024-08-22
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
Browse: 258   Download: 608   Issue Date: 2024-08-22
Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
Browse: 265   Download: 543   Issue Date: 2024-08-22
Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
Browse: 208   Download: 421   Issue Date: 2024-08-22
Rocahepevirus ratti: An underrecognised cause of acute hepatitis
Browse: 166   Download: 452   Issue Date: 2024-08-22
Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
Browse: 305   Download: 716   Issue Date: 2024-07-26
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
Browse: 316   Download: 802   Issue Date: 2024-07-26
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
Browse: 297   Download: 601   Issue Date: 2024-07-26
Interleukin-mediated therapies in liver diseases and comorbidity effects
Browse: 309   Download: 683   Issue Date: 2024-07-26
Roles of transforming growth factor-β signaling in liver disease
Browse: 344   Download: 602   Issue Date: 2024-07-26
Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
Browse: 252   Download: 691   Issue Date: 2024-06-27
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
Browse: 216   Download: 875   Issue Date: 2024-06-27
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Browse: 202   Download: 540   Issue Date: 2024-06-27
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Browse: 197   Download: 499   Issue Date: 2024-06-27
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
Browse: 190   Download: 532   Issue Date: 2024-06-27
Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
Browse: 290   Download: 992   Issue Date: 2024-05-27
Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
Browse: 281   Download: 688   Issue Date: 2024-05-27
Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
Browse: 211   Download: 543   Issue Date: 2024-05-27
Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
Browse: 242   Download: 589   Issue Date: 2024-05-27
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
Browse: 273   Download: 607   Issue Date: 2024-05-27